For developing a bioartificial liver (BAL) device, an attractive alternativ
e to the primary human hepatocytes would be the use of highly differentiate
d immortalized human hepatocytes with a safeguard. To test the feasibility,
the primary human hepatocytes were immortalized by a plasmid SV3neo encodi
ng simian virus 40 large T antigen (SV40Tag) gene. A highly differentiated
hepatocyte line OUMS-29 was established. A suicide gene of herpes simplex v
irus-thymidine kinase (HSV-TK) was retrovirally introduced into OUMS-29 cel
ls as a safeguard for clinical application. One of the resulting HSV-TK-pos
itive Cell lines, OUMS-29/tk, grew in chemically defined serum-free medium
with the gene expression of differentiated liver functions. OUMS-29/tk cell
s were 100 times more sensitive to ganciclovir compared with unmodified OUM
S-29 cells in in vitro experiments. We have established a tightly regulated
immortalized human hepatocyte cell line. Essentially unlimited availabilit
y of OUMS-29/tk cells may be clinically useful for BAL therapy.